{
    "2019-08-06": [
        [
            {
                "time": "2019-08-06",
                "original_text": "The Opioid Crisis Canâ€™t Be Engineered Away",
                "features": {
                    "keywords": [
                        "opioid crisis",
                        "engineered"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-08-06",
                "original_text": "Health Care Sector Update for 08/06/2019: BDX, BHC, MNK, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "health care sector",
                        "BDX",
                        "BHC",
                        "MNK",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-08-06",
                "original_text": "What You'll Want to Know About Arrowhead Pharmaceuticals' Q3 Update",
                "features": {
                    "keywords": [
                        "Arrowhead Pharmaceuticals",
                        "Q3 update"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-08-06",
                "original_text": "How Analysts View Arrowhead Pharmaceuticals",
                "features": {
                    "keywords": [
                        "analysts view",
                        "Arrowhead Pharmaceuticals"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}